The Effects of 4-Methylethcathinone on Conditioned Place Preference, Locomotor Sensitization, and Anxiety-Like Behavior: A Comparison with Methamphetamine

International Journal of Neuropsychopharmacology

Volumn 19, Issue 4, 2016, Pages

  Xu, Peng ^a   Qiu, Yi ^b   Zhang, Yizhi ^b,c   Bai, Yanping ^a   Xu, Pengfei ^a   Liu, Yuan ^a   Kim, Jee Hyun ^d   Shen, Hao Wei ^b  

^a INSTITUTE OF FORENSIC SCIENCE   (China)

^b PEKING UNIVERSITY   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

4 methylethcathinone; CPP; elevated plus maze; locomotor sensitization

Indexed keywords

4' METHYLMETHCATHINONE; METHAMPHETAMINE; SODIUM CHLORIDE; 4-METHYLETHCATHINONE; AMPHETAMINE DERIVATIVE; CENTRAL NERVOUS SYSTEM AGENTS; PROPIOPHENONE DERIVATIVE;

ADDICTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR ASSESSMENT; COMPARATIVE STUDY; CONDITIONING; CONTROLLED STUDY; ELEVATED PLUS MAZE TEST; LOCOMOTION; MALE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; SENSITIZATION; ANIMAL; CHEMICALLY INDUCED; DOSE RESPONSE; DRUG EFFECTS; MOTOR ACTIVITY; REWARD; SPATIAL BEHAVIOR; SPRAGUE DAWLEY RAT; WITHDRAWAL SYNDROME;

AMPHETAMINES; ANIMALS; ANXIETY; CENTRAL NERVOUS SYSTEM AGENTS; CONDITIONING (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; METHAMPHETAMINE; MOTOR ACTIVITY; PROPIOPHENONES; RATS, SPRAGUE-DAWLEY; REWARD; SPATIAL BEHAVIOR; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84966393363     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1093/ijnp/pyv120     Document Type: Article

References (32)

1. Bardo MT, Bevins RA (2000) Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology (Berl) 153:31-43.
2. China Food and Drug Administration (2013) Catalogs of the controlled psychotropic drugs.
3. De Felice LJ, Glennon RA, Negus SS (2014) Synthetic cathinones: chemical phylogeny, physiology, and neuropharmacology. Life Sci 97:20-26.
4. Eisener-Dorman AF, Grabowski-Boase L, Tarantino LM (2011) Cocaine locomotor activation, sensitization and place preference in six inbred strains of mice. Behav Brain Funct 7:29.
5. El Hage C, Rappeneau V, Etievant A, Morel AL, Scarna H, Zimmer L, Berod A (2012) Enhanced anxiety observed in cocaine withdrawn rats is associated with altered reactivity of the dorsomedial prefrontal cortex. PLoS ONE 7:e43535.
6. Gatch MB, Rutledge MA, Forster MJ (2015) Discriminative and locomotor effects of five synthetic cathinones in rats and mice. Psychopharmacology (Berl) 232:1197-1205.
7. Gregg RA, Tallarida CS, Reitz A, McCurdy C, Rawls SM (2013) Mephedrone (4-methylmethcathinone), a principal constituent of psychoactive bath salts, produces behavioral sensitization in rats. Drug Alcohol Depend 133:746-750.
8. Hogg S (1996) A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav 54:21-30.
9. Kitanaka N, Kitanaka J, Tatsuta T, Tanaka K, Watabe K, Nishiyama N, Morita Y, Takemura M (2010) Withdrawal from fixed-dose injection of methamphetamine decreases cerebral levels of 3-methoxy-4-hydroxyphenylglycol and induces the expression of anxiety-related behavior in mice. Neurochem Res 35:749-760.
10. Knackstedt LA, Kalivas PW (2007) Extended access to cocaine self-administration enhances drug-primed reinstatement but not behavioral sensitization. J Pharmacol Exp Ther 322:1103-1109.
11. Liechti ME, Baumann C, Gamma A, Vollenweider FX (2000) Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram. Neuropsychopharmacology 22:513-521.
12. Lisek R, Xu W, Yuvasheva E, Chiu YT, Reitz AB, Liu-Chen LY, Rawls SM (2012) Mephedrone ('bath salt') elicits conditioned place preference and dopamine-sensitive motor activation. Drug Alcohol Depend 126:257-262.
13. Naylor JE, Freeman KB, Blough BE, Woolverton WL, Huskinson SL (2015) Discriminative-stimulus effects of second generation synthetic cathinones in methamphetamine-trained rats. Drug Alcohol Depend 149:280-284.
14. Perrine SA, Sheikh IS, Nwaneshiudu CA, Schroeder JA, Unterwald EM (2008) Withdrawal from chronic administration of cocaine decreases delta opioid receptor signaling and increases anxiety- and depression-like behaviors in the rat. Neuropharmacology 54:355-364.
15. Pickens CL, Airavaara M, Theberge F, Fanous S, Hope BT, Shaham Y (2011) Neurobiology of the incubation of drug craving. Trends Neurosci 34:411-420.
16. Pierce RC, Kalivas PW (1997) A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev 25:192-216.
17. Pometlova M, Nohejlova-Deykun K, Slamberova R (2012) Anxiogenic effect of low-dose methamphetamine in the test of elevated plus-maze. Prague Med Rep 113:223-230.
18. Ross EA, Reisfield GM, Watson MC, Chronister CW, Goldberger BA (2012) Psychoactive "bath salts" intoxication with methylenedioxypyrovalerone. Am J Med 125:854-858.
19. Rothman RB, Baumann MH (2006) Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs. Ann N Y Acad Sci 1074:245-260.
20. Saha K, Partilla JS, Lehner KR, Seddik A, Stockner T, Holy M, Sandtner W, Ecker GF, Sitte HH, Baumann MH (2015) 'Second-generation' mephedrone analogs, 4-MEC and 4-MePPP, differentially affect monoamine transporter function. Neuropsychopharmacology 40:1321-1331.
21. Shen HW, Toda S, Moussawi K, Bouknight A, Zahm DS, Kalivas PW (2009) Altered dendritic spine plasticity in cocaine-withdrawn rats. J Neurosci 29:2876-2884.
22. Simmler LD, Rickli A, Hoener MC, Liechti ME (2014) Monoamine transporter and receptor interaction profiles of a new series of designer cathinones. Neuropharmacology 79:152-160.
23. Singh S, Goswami P, Swarnkar S, Singh SP, Wahajuddin, Nath C, Sharma S (2011) A study to evaluate the effect of nootropic drug-piracetam on DNA damage in leukocytes and macrophages. Mutat Res 726:66-74.
24. Steketee JD, Kalivas PW (2011) Drug wanting: behavioral sensitization and relapse to drug-seeking behavior. Pharmacol Rev 63:348-365.
25. Tamaki R, Yoshikawa M, Shinomiya T, Hashimoto A, Kawaguchi M, Byrne DW, Kobayashi H (2008) Acute administration of methamphetamine decreases the mRNA expression of diazepam binding inhibitor in rat brain. Tokai J Exp Clin Med 33:51-56.
26. Tzschentke TM (2007) Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol 12:227-462.
27. United States Department of Justice (2014) Schedules of controlled substances: temporary placement of 10 synthetic cathinones into Schedule I. Federal Register 79:4429.
28. Valente MJ, Guedes de Pinho P, de Lourdes Bastos M, Carvalho F, Carvalho M (2014) Khat and synthetic cathinones: a review. Arch Toxicol 88:15-45.
29. Watterson LR, Burrows BT, Hernandez RD, Moore KN, Grabenauer M, Marusich JA, Olive MF (2015) Effects of alpha-pyrrolidinovalerophenone (alpha-PVP) and 4-methylethcathinone (4-MEC), two synthetic cathinones commonly found in second-generation "bath salts", on ICSS thresholds in rats. Int J Neuropsychopharmacol 18:1-7.
30. Wee S, Anderson KG, Baumann MH, Rothman RB, Blough BE, Woolverton WL (2005) Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs. J Pharmacol Exp Ther 313:848-854.
31. World Health Organization (2014) 4-Methylethcathinone (4-MEC): critical review report. Expert Committee on Drug Dependence. 36th ECDD Agenda item 4.15.
32. Xu P, Li M, Bai Y, Lu W, Ling X, Li W (2015) The effects of piracetam on heroin-induced CPP and neuronal apoptosis in rats. Drug Alcohol Depend 150:141-146.